Autoimmune responses directed against the central nervous system (CNS) have
generally been considered pathogenic in nature. Although there are several
well understood conditions in which this is the case, there is also a grow
ing body of experimental evidence to show that both the cellular and humora
l immune responses can promote tissue repair following CNS injury and disea
se. Our laboratory has used a mouse model of chronic demyelinating disease
to characterize a class of polyreactive IgM autoantibodies that react with
oligodendrocyte surface antigens and promote myelin repair. By screening a
large number of human monoclonal antibodies, we have found that IgM antibod
ies that react with CNS tissue are relatively common. Autoreactive IgM anti
bodies might constitute an endogenous system for tissue repair, and therefo
re these antibodies could be of value as therapeutic reagents.